829 / 1726
Indications for combined intracavitary/interstitial
•
middle/distal parametrial tumor extension
•
unfavourable topography/unfavourable relation to
the applicator (e.g. asymmetrical tumors)
(depending on applicator position)
•
distal intravaginal tumor growth
•
para-vaginal tumor growth
•
unfavourable topography of organs at risk
(not predictable – correction within the frame of
subsequent applications)